Bayer overhauls its trial planning process

TCS ADD^TM is happy to partner with Bayer in its vision to revamp its clinical trial planning process including patient and site recruitment, preparing protocols and conducting planning for trials. We implemented the data driven feasibility solution of TCS ADDAnalytics and Insights to generate actionable insights that incorporated real-world data (RWD). In addition, the eSurvey solution mapped to TCS ADD Connected Clinical Trials Platform aided site personnel to remotely and electronically engage in conversation with Bayer representatives and record their response.

Introducing analytics into the development of study protocols has allowed us data-driven decision making. We already see improvements in study conduct, which will help us to get new medicines to patients faster.

DR.SUBRATA BOSE

Global Head of Clinical Trials, Analytics and Insights Bayer AG

About the author

Dr. Subrata Bose

Using AI and imaging to combat diseases. Leading a global team consisting extremely talented Radiologists,Data Scientists, Program Managers, System Engineers and Problem Solvers to develop applications to detect, monitor and treat life threatening diseases using imaging and AI. Winner of several multimillion pounds AI /imaging research awards from EU, London Development Agency and leading UK University.

TCS is here to make a difference through technology.

We’re in it for good, driving positive change for the benefit of all.

Recent News

Extraordinary expertise leads to remarkable results.

Want to be a global change-maker? Join our team.

TCS works hand in hand with world-leading investors.

TCS is here to make a difference through technology.

We’re in it for good, driving positive change for the benefit of all.

Recent News

Extraordinary expertise leads to remarkable results.

Want to be a global change-maker? Join our team.

TCS works hand in hand with world-leading investors.

Bayer overhauls it’s clinical trial planning process

Dr. Subrata Bose

Global Head of Clinical Trials, Analytics and Insights Bayer AG

Your download is ready

Introducing analytics into the development of study protocols has allowed us data-driven decision making. We already see improvements in study conduct, which will help us to get new medicines to patients faster.

DR.SUBRATA BOSE

About the author

Dr. Subrata Bose

Transformation starts here

TCS is here to make a difference through technology.

We’re in it for good, driving positive change for the benefit of all.

Recent News

Extraordinary expertise leads to remarkable results.

Want to be a global change-maker? Join our team.

TCS works hand in hand with world-leading investors.

TCS is here to make a difference through technology.

We’re in it for good, driving positive change for the benefit of all.

Recent News

Extraordinary expertise leads to remarkable results.

Want to be a global change-maker? Join our team.

TCS works hand in hand with world-leading investors.

Bayer overhauls it’s clinical trial planning process

Dr. Subrata Bose

Global Head of Clinical Trials, Analytics and Insights Bayer AG

Your download is ready

Introducing analytics into the development of study protocols has allowed us data-driven decision making. We already see improvements in study conduct, which will help us to get new medicines to patients faster.

DR.SUBRATA BOSE

About the author

Dr. Subrata Bose

Related reading

Transforming PV Efficiencies with ML and Rule-based Automation

Digital Data Flow and Technological Solution Providers

Next-gen clinical trials on a digital platform

Adopting a Design Thinking Approach for Risk-Based Monitoring

Transformation starts here